Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1959 1
1962 1
1969 2
1974 4
1975 4
1976 1
1977 5
1978 3
1979 3
1980 2
1981 1
1982 5
1983 4
1984 8
1985 6
1986 10
1987 3
1988 7
1989 5
1990 8
1991 2
1992 6
1993 3
1994 2
1995 4
1996 5
1997 4
1998 5
1999 4
2000 11
2001 12
2002 6
2003 12
2004 10
2005 12
2006 12
2007 7
2008 15
2009 10
2010 10
2011 14
2012 20
2013 9
2014 17
2015 16
2016 16
2017 18
2018 23
2019 34
2020 32
2021 20
2022 16
2023 32
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

482 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial.
Laffel LM, Danne T, Klingensmith GJ, Tamborlane WV, Willi S, Zeitler P, Neubacher D, Marquard J; DINAMO Study Group. Laffel LM, et al. Lancet Diabetes Endocrinol. 2023 Mar;11(3):169-181. doi: 10.1016/S2213-8587(22)00387-4. Epub 2023 Feb 1. Lancet Diabetes Endocrinol. 2023. PMID: 36738751 Free PMC article. Clinical Trial.
Nrf2/Keap1/ARE signaling: Towards specific regulation.
Ulasov AV, Rosenkranz AA, Georgiev GP, Sobolev AS. Ulasov AV, et al. Among authors: sobolev as. Life Sci. 2022 Feb 15;291:120111. doi: 10.1016/j.lfs.2021.120111. Epub 2021 Oct 31. Life Sci. 2022. PMID: 34732330 Free PMC article. Review.
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Marso SP, et al. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605603 Free PMC article. Clinical Trial.
Selected strategies to fight pathogenic bacteria.
Plotniece A, Sobolev A, Supuran CT, Carta F, Björkling F, Franzyk H, Yli-Kauhaluoma J, Augustyns K, Cos P, De Vooght L, Govaerts M, Aizawa J, Tammela P, Žalubovskis R. Plotniece A, et al. Among authors: sobolev a. J Enzyme Inhib Med Chem. 2023 Dec;38(1):2155816. doi: 10.1080/14756366.2022.2155816. J Enzyme Inhib Med Chem. 2023. PMID: 36629427 Free PMC article. Review.
NMR-Based Approaches in the Study of Foods.
Sobolev AP, Ingallina C, Spano M, Di Matteo G, Mannina L. Sobolev AP, et al. Molecules. 2022 Nov 15;27(22):7906. doi: 10.3390/molecules27227906. Molecules. 2022. PMID: 36432006 Free PMC article. Review.
Handling Metadata in a Neurophysiology Laboratory.
Zehl L, Jaillet F, Stoewer A, Grewe J, Sobolev A, Wachtler T, Brochier TG, Riehle A, Denker M, Grün S. Zehl L, et al. Among authors: sobolev a. Front Neuroinform. 2016 Jul 19;10:26. doi: 10.3389/fninf.2016.00026. eCollection 2016. Front Neuroinform. 2016. PMID: 27486397 Free PMC article.
Transcription factors: Time to deliver.
Ulasov AV, Rosenkranz AA, Sobolev AS. Ulasov AV, et al. Among authors: sobolev as. J Control Release. 2018 Jan 10;269:24-35. doi: 10.1016/j.jconrel.2017.11.004. Epub 2017 Nov 4. J Control Release. 2018. PMID: 29113792 Review.
Editorial: Targeted Subcellular Delivery of Anti-cancer Agents.
Jans DA, Sobolev AS. Jans DA, et al. Among authors: sobolev as. Front Pharmacol. 2019 Jan 22;9:1577. doi: 10.3389/fphar.2018.01577. eCollection 2018. Front Pharmacol. 2019. PMID: 30723414 Free PMC article. No abstract available.
482 results